Optipharm.CO.LTD (153710) - Total Liabilities

Latest as of December 2025: ₩15.37 Billion KRW ≈ $10.42 Million USD

Based on the latest financial reports, Optipharm.CO.LTD (153710) has total liabilities worth ₩15.37 Billion KRW (≈ $10.42 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 153710 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Optipharm.CO.LTD - Total Liabilities Trend (2015–2025)

This chart illustrates how Optipharm.CO.LTD's total liabilities have evolved over time, based on quarterly financial data. See 153710 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Optipharm.CO.LTD Competitors by Total Liabilities

The table below lists competitors of Optipharm.CO.LTD ranked by their total liabilities.

Company	Country	Total Liabilities
Ozderici Gayrimenkul Yatirim Ortakligi AS IS:OZGYO	Turkey	TL364.02 Million
Lexibook Linguistic Electronic System SA PA:ALLEX	France	€30.78 Million
Tanami Gold NL AU:TAM	Australia	AU$5.12 Million
Kodiak Copper Corp V:KDK	Canada	CA$5.11 Million
Mawana Sugars Limited NSE:MAWANASUG	India	Rs5.98 Billion
IGM Biosciences Inc NASDAQ:IGMS	USA	$6.06 Million
ROK Resources Inc V:ROK	Canada	CA$35.39 Million
Classic Scenic Bhd KLSE:7202	Malaysia	RM40.99 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Optipharm.CO.LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Optipharm.CO.LTD.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Optipharm.CO.LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Optipharm.CO.LTD (2015–2025)

The table below shows the annual total liabilities of Optipharm.CO.LTD from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩15.37 Billion ≈ $10.42 Million	-3.84%
2024-12-31	₩15.98 Billion ≈ $10.83 Million	+13.11%
2023-12-31	₩14.13 Billion ≈ $9.58 Million	+16.10%
2022-12-31	₩12.17 Billion ≈ $8.25 Million	+19.17%
2021-12-31	₩10.21 Billion ≈ $6.92 Million	+35.43%
2020-12-31	₩7.54 Billion ≈ $5.11 Million	+23.42%
2019-12-31	₩6.11 Billion ≈ $4.14 Million	-15.07%
2018-12-31	₩7.20 Billion ≈ $4.88 Million	+1.97%
2017-12-31	₩7.06 Billion ≈ $4.78 Million	-0.27%
2016-12-31	₩7.08 Billion ≈ $4.79 Million	-46.06%
2015-12-31	₩13.12 Billion ≈ $8.89 Million	--

About Optipharm.CO.LTD

KQ:153710 Korea Diagnostics & Research

Market Cap

$46.48 Million

₩68.58 Billion KRW

Market Cap Rank

#22114 Global

#1341 in Korea

Share Price

₩4675.00

Change (1 day)

+1.30%

52-Week Range

₩4260.00 - ₩6200.00

All Time High

₩28900.00